We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1216:TWSEUni-President Enterprises Corp. Analysis

Data as of 2026-05-26 - not real-time

HK$0.32

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Zhongyuan Bank is trading at HK$0.315, well under its 20‑day (0.323), 50‑day (0.327) and 200‑day (0.330) simple moving averages, signaling a bearish price stance. The RSI of 42.8 and a bearish MACD histogram reinforce the downtrend, while volume has slipped sharply from an average of over 1 million shares to just 8,000 today, indicating waning market interest. Valuation metrics are exceptionally cheap – a trailing P/E of 3.5 versus an industry average of 16.8 and a P/B of 0.12 suggest the stock is deeply undervalued. The dividend yield of 4.11% looks attractive, but the low payout ratio (15%) masks underlying cash pressure, as operating cash flow is negative and free cash flow is nil. Profitability is modest, with ROE at 3.6% and ROA at 0.26%, and revenue growth barely above 1.8%, underscoring limited growth momentum. Volatility is high at 29% over the past 30 days, yet beta is low at 0.38, meaning the stock moves less than the broader market. Overall, the stock presents a classic value case marred by weak earnings quality and liquidity constraints.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below key support levels and all SMAs
  • Bearish MACD and RSI below 50
  • Sharp decline in trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Significant valuation discount (low P/E and P/B)
  • High dividend yield relative to peers
  • Continued cash‑flow weakness and modest profitability

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Deep value positioning offers upside if earnings recover
  • Potential for dividend stability if cash flow improves
  • Low beta suggests limited market‑wide volatility exposure

Key Metrics & Analysis

Financial Health

Revenue Growth1.80%
Profit Margin28.05%
P/E Ratio3.5
ROE3.58%
ROA0.26%
P/B Ratio0.1
Op. Cash FlowHK$-131417000
Industry P/E16.8

Technical Analysis

TrendBearish
RSI42.8
SupportHK$0.30
ResistanceHK$0.34
MA 20HK$0.32
MA 50HK$0.33
MA 200HK$0.33
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

GradeUndervalued
TypeValue
Dividend Yield4.11%

Risk Assessment

Beta0.38
Volatility29.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.